Minimal Residual Disease Testing Market Size to Reach USD 4.72 Billion by 2034
HealthcareThe global Minimal Residual Disease (MRD) Testing Market is poised for remarkable growth, expanding from USD 1.70 billion in 2025 to an anticipated USD 4.72 billion by 2034, growing at a robust CAGR of 12.00%. This upward trajectory is fueled by rising cancer prevalence worldwide, especially hematological malignancies, and the integration of highly sensitive technologies […]